CClinicalTrials.gg
RecruitingNCT07013695VIRTUALRUpdated Jun 10, 2025

Evaluation of the Impact of Virtual Reality on Sedation Use in Patients Undergoing Regional Anesthesia for Scheduled Orthopedic Surgery

An interventional study of Virtual reality headset and Standard Care (in control arm) in Orthopedic Procedure, Anesthesia and Sedation, sponsored by Centre Hospitalier Eure-Seine. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-10.

Sponsored by Centre Hospitalier Eure-Seine · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Registered 10 months after the study started (first participant enrolled Jul 2024, registered May 2025).
  • Started Jul 2024; still recruiting 2 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
164
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The VIRTUALR study evaluates the effect of virtual reality combined with hypnosis on anxiety in patients undergoing orthopedic surgery under regional anesthesia. Patients are randomly assigned to two groups: one group receiving virtual reality and a control group without the device. Anxiety and satisfaction questionnaires are used to compare the two groups.

02

Conditions studied

  • Orthopedic Procedure
  • Anesthesia
  • Sedation
03

In context

Lead sponsor

Centre Hospitalier Eure-Seine is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Signed informed consent
  • Patient affiliated with or benefiting from a social security system
  • Patient aged 18 years or older
  • Patient requiring regional anesthesia for scheduled orthopedic surgery of the upper or lower limb

Exclusion criteria

Exclusion Criteria:

  • Patient refusal to participate in the study
  • Device interfering with the surgical or anesthetic procedure
  • Premedication before arrival in the operating room
  • Psychiatric or cognitive disorders, communication disorders
  • Patient unable to understand the study (language barrier, psychological issues)
  • Emergency surgery
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
164 participants (estimated)

Study arms

  • Active comparator
    virtual reality group

    Participants in this group receive a virtual reality session with a hypnotic objective during surgery performed under regional anesthesia. The device consists of a virtual reality headset offering immersive visual and auditory content in a calming environment chosen by the participant. The session begins before the administration of regional anesthesia and may continue throughout the surgical procedure.

    Device: Virtual reality headset

  • Placebo comparator
    Control Group

    Participants in this group receive standard anesthetic and surgical care without the use of virtual reality.

    Other: Standard Care (in control arm)

Interventions

  • DeviceVirtual reality headset

    Patients in the intervention group receive a virtual reality session with a hypnotic purpose during surgery under regional anesthesia. The device consists of a virtual reality headset providing visual and auditory immersion in a calming environment, freely chosen by the patient. The session begins before the regional anesthesia is administered and may continue throughout the entire surgical procedure

  • OtherStandard Care (in control arm)

    Participants in this group receive standard anesthetic and surgical care without the use of virtual reality

06

What researchers measure

Primary outcomes

  1. Comparison of sedation use rates between the experimental group and the control group (level 0 versus ≥1).

    Proportion of patients who required sedation (at level ≥1) during regional anesthesia or surgery, compared to those who did not receive sedation (level 0). Sedation levels are defined according to a standardized scale.

    Time frame: Intraoperative period (from arrival in the operating room to the end of surgery)

Secondary outcomes

  1. Mean age of patients

    Mean age of patient in each group at baseline

    Time frame: Baseline (before anesthesia consultation or at inclusion)

  2. Sex distribution

    Number of male and female patients in each group

    Time frame: Baseline (before anesthesia consultation or at inclusion)

  3. type of surgery

    Distribution of types of surgery performed in each group

    Time frame: Baseline (before anesthesia consultation or at inclusion)

  4. ASA score distribution

    Distribution of ASA physical status scores among patients in each group

    Time frame: Baseline (before anesthesia consultation or at inclusion)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07013695
Lead sponsor
Centre Hospitalier Eure-Seine
Responsible party
Sponsor
First posted
Jun 10, 2025
Start date
Jul 18, 2024
Primary completion
Jul 17, 2025 (estimated)
Completion
Jul 19, 2025 (estimated)
Last update
Jun 10, 2025

Study contacts

Lydia BEN BEKKOU
Contact
arc2.circe@ch-eureseine.fr
02 32 33 86 75
Dihia AIDENE
Contact
arc.circe@ch-eureseine.fr
02 32 33 86 75
Jean-Baptiste HARDY
principal investigator · Centre Hospitalier Eure-Seine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion